Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Lalan Wilfong, MD, explains how OCM has impacted cancer patients in his practice

Dr. Wilfong, Director of Quality Programs for Texas Oncology; Physician Champion for OCM at McKesson Specialty Health, shares how OCM is affecting the cancer patients in his practice

Tags: COA Conference CoverageOncology Care Model (OCM)Policy and Value (includes Cost, Quality, Reimbursement, Guidelines, Pathways, Insurance)

Published: 04 May 2017

Recent Videos

video

Rana McKay, MD, discusses factors considered when deciding which patients to get an I-O combo in RCC

Dr. McKay, Assistant Professor of Medicine, UCSD, discusses factors she considers in deciding which patients should get an I-O combination ...

video

Rana McKay, MD, discusses the unmet needs for clinical trials addressing non-clear cell RCC

Dr. McKay, Assistant Professor of Medicine, UCSD, discusses the unmet needs for clinical trials addressing non-clear cell renal cell carcinoma

video

Rana McKay, MD, shares results of the randomized Phase 2 study investigating luPSMA vs cabazitaxel

Dr. McKay, Assistant Professor of Medicine, UCSD, shares the results of the randomized Phase 2 study investigating luPSMA vs cabazitaxel ...

video

Rana McKay, MD, dissects the pros and cons of the virtual format of ASCO20

Dr. McKay, Assistant Professor of Medicine, UCSD, dissects the pros and cons of the virtual format of ASCO20 and some ...

video

Rana McKay, MD, elaborates on the advent of hormonal agents for patients with metastatic prostate cancer

Dr. McKay, Assistant Professor of Medicine, UCSD, elaborates on how the advent of hormonal agents for patients with metastatic prostate ...

video

Rana McKay MD, explains approach to treating 2nd-line RCC patients who have received I-O combination

Dr. McKay, Assistant Professor of Medicine, UCSD, explains approach to treating 2nd-line renal cell carcinoma (RCC) patients who have received ...

video

Rana McKay, MD, discusses the design and outcomes of the Phase 3 randomized Keynote 426 study in 1st line clear cell renal cell cancer (RCC)

Dr. McKay, Assistant Professor of Medicine, UCSD, discusses the design and outcomes of the Phase 3 randomized Keynote 426 study ...

video

Rana McKay, MD, shares the design and outcomes of the Javelin Bladder 100 study

Dr. McKay, Assistant Professor of Medicine, UCSD, shares the design and outcomes of the Javelin Bladder 100 study investigating maintenance ...

video

Robert Coleman, MD, describes experience with virtual ASCO20

Dr. Coleman, Chief Scientific Officer, US Oncology Network, describes experience with virtual ASCO20

video

Joyce Liu, MD, describes experience with virtual ASCO20

Dr. Liu, Assistant Professor of Medicine, Dana-Farber Cancer Institute, describes experience with virtual ASCO20

Related Videos

video-image

Rana McKay, MD, discusses the unmet needs for clinical trials addressing non-clear cell RCC

video-image

Rana McKay, MD, discusses factors considered when deciding which patients to get an I-O combo in RCC

video-image

Rana McKay, MD, shares results of the randomized Phase 2 study investigating luPSMA vs cabazitaxel

video-image

Rana McKay, MD, shares the design and outcomes of the Javelin Bladder 100 study

video-image

Rana McKay, MD, discusses the design and outcomes of the Phase 3 randomized Keynote 426 study in 1st line clear cell renal cell cancer (RCC)

video-image

Rana McKay MD, explains approach to treating 2nd-line RCC patients who have received I-O combination

video-image

Rana McKay, MD, elaborates on the advent of hormonal agents for patients with metastatic prostate cancer

video-image

Rana McKay, MD, dissects the pros and cons of the virtual format of ASCO20

video-image

Joyce Liu, MD, describes experience with virtual ASCO20

video-image

Robert Coleman, MD, describes experience with virtual ASCO20

video-image

Sara Hurvitz, MD, shares design and outcomes of the HER2CLIMB study in advanced breast cancer

video-image

Sara Hurvitz, MD, discusses the recently announced results of Monarch E and PALLAS adjuvant trials

video-image

Sara Hurvitz, MD, describes the recently reported results using PARP inhibition and cisplatin

video-image

Debu Tripathy, MD, discusses recent FDA approvals and HER2+ metastatic breast cancer management

video-image

Debu Tripathy, MD, on presentations pertaining to immunotherapy in early breast cancer treatment

video-image

Debu Tripathy, MD, introduces new information onCDK4/6 inhibitors discussed at ASCO20

video-image

Debu Tripathy, MD, describes the evolving role of PARP inhibitors in breast cancer patients

video-image

Dana Chase, MD, FACOG, shares thoughts on the role of I-O in GTT management

video-image

Toni Choueiri, MD, describes treatment strategies for 2nd line renal cell carcinoma

video-image

Derek Raghavan, MD, discusses Mobile screening Chest CT project for use in underserved populations